NCIt definition : A pyrazinecarboxamide derivative with activity against RNA viruses. Favipiravir is
converted to the ribofuranosyltriphosphate derivative by host enzymes and selectively
inhibits the influenza viral RNA-dependent RNA polymerase.;
UNII : EW5GL2X7E0;
InChIKey : ZCGNOVWYSGBHAU-UHFFFAOYSA-N;
CAS number : 259793-96-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 259793-96-9
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
https://www.cochrane.org/fr/CD015219/INFECTN_le-favipiravir-est-il-utile-dans-le-traitement-des-personnes-atteintes-de-covid-19 2024 United Kingdom review of literature french abstract No Treatment for Diabetes COVID-19 Treat During Treatment Israel disease favipiravir Illinois People Treatment Study favipiravir Therapy Object Treatment Treatment Epoch persons COVID-19 Infection Biomaterial Treatment What Month is it Favipiravir GDC Treatment Frequency Terminology On Treatment Interleukin